October 18, 2024 — Neurophth Biotechnology Co., Ltd. ("Neurophth Biology") welcomed a visit and guidance from Professor Shihui Wei, a leading figure in neuro-ophthalmology in China. Professor Wei holds multiple prestigious titles, including Leader of the Neuro-Ophthalmology Group of the Ophthalmology Branch of the Chinese Medical Association, Director of the Neuro-Ophthalmology Committee of the Chinese Ophthalmologist Association, Director of the Neuro-Ophthalmology Committee of the Chinese Research Hospital Association, and Professor of Ophthalmology at the General Hospital of the Chinese People's Liberation Army.

Mr. Min Zhang, Vice President of Process Development, and Mr. Zhengbin Li, Vice President of Commercial Operations, along with other company representatives, warmly received Professor Wei and delivered welcoming remarks. The Neurophth team provided Professor Wei with an overview of the company’s development history, facility operations, and progress in its neuro-ophthalmology gene therapy product pipeline. Professor Wei commended Neurophth’s achievements and encouraged the team to continue advancing their efforts.

Laboratory and Facility Tour

Following the presentation, Professor Wei and his delegation toured Neurophth’s laboratories and production facilities under the guidance of technical management staff. As China’s first independent AAV production facility compliant with GMP standards, Neurophth’s advanced equipment, stringent management protocols, and rigorous scientific environment earned high praise from the visiting experts.

Gratitude and Future Aspirations

Neurophth Biology expressed sincere gratitude to the Neuro-Ophthalmology Group of the Chinese Medical Association for its long-standing guidance and support. The visit by Professor Wei and his team reaffirmed confidence in the company’s work. Neurophth looks forward to achieving further breakthroughs in neuro-ophthalmology gene therapy under the guidance of experts and academic groups, while continuing to contribute to advancements in China’s neuro-ophthalmology field and patient care.